Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Eyes In-House GLP-1 Development – Apart From ‘Key’ APIs
Device Manufacture And Fill-Finish Part Of Internal Capabilities
Sep 29 2022
•
By
Dean Rudge
Sandoz will use both its in-house capabilities and partnerships • Source: Shutterstock
More from Archive
More from Generics Bulletin